1. Home
  2. Publications
  3. Tale of two erythropoiesis-stimulating agents: utilization, dosing, litigation, and costs of darbepoetin and epoetin among South Carolina Medicaid-covered patients with cancer and chemotherapy-induced anemia

Tale of two erythropoiesis-stimulating agents: utilization, dosing, litigation, and costs of darbepoetin and epoetin among South Carolina Medicaid-covered patients with cancer and chemotherapy-induced anemia

Noxon, Virginia, Kevin B Knopf, LeAnn B Norris, and . 2017. “Tale of Two Erythropoiesis-Stimulating Agents: Utilization, Dosing, Litigation, and Costs of Darbepoetin and Epoetin Among South Carolina Medicaid-Covered Patients With Cancer and Chemotherapy-Induced Anemia”. Journal of Oncology Practice 13 (6): e562—e573.
Last updated on 05/25/2023